RhumbLine Advisers
AHCO icon

RhumbLine Advisers’s AdaptHealth AHCO Stock Holding History

RhumbLine Advisers’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.73M Sell
261,632
-48,760
-16% -$544K ﹤0.01% 1785
2026
Q1 		$3.69M Buy
310,392
+13,033
+4% +$133K ﹤0.01% 1555
2025
Q4 		$2.96M Sell
297,359
-12,877
-4% -$123K ﹤0.01% 1666
2025
Q3 		$2.78M Buy
310,236
+10,218
+3% +$94.6K ﹤0.01% 1727
2025
Q2 		$2.83M Sell
300,018
-3,136
-1% -$27.7K ﹤0.01% 1696
2025
Q1 		$3.29M Sell
303,154
-9,956
-3% -$100K ﹤0.01% 1569
2024
Q4 		$2.98M Buy
313,110
+1,691
+0.5% +$17.1K ﹤0.01% 1681
2024
Q3 		$3.5M Buy
311,419
+40,386
+15% +$429K ﹤0.01% 1608
2024
Q2 		$2.71M Buy
271,033
+3,498
+1% +$35.5K ﹤0.01% 1721
2024
Q1 		$3.08M Buy
267,535
+2,332
+0.9% +$19.8K ﹤0.01% 1675
2023
Q4 		$1.93M Buy
265,203
+14,503
+6% +$114K ﹤0.01% 1921
2023
Q3 		$2.28M Buy
250,700
+31,061
+14% +$372K ﹤0.01% 1793
2023
Q2 		$2.67M Sell
219,639
-11,986
-5% -$134K ﹤0.01% 1744
2023
Q1 		$2.88M Buy
231,625
+10,988
+5% +$202K ﹤0.01% 1620
2022
Q4 		$4.24M Sell
220,637
-8,814
-4% -$186K 0.01% 1377
2022
Q3 		$4.31M Buy
229,451
+127,301
+125% +$2.62M 0.01% 1322
2022
Q2 		$1.84M Buy
102,150
+9,902
+11% +$161K ﹤0.01% 1803
2022
Q1 		$1.48M Sell
92,248
-9,254
-9% -$166K ﹤0.01% 1960
2021
Q4 		$2.48M Buy
101,502
+593
+0.6% +$13.9K ﹤0.01% 1761
2021
Q3 		$2.35M Sell
100,909
-3,486
-3% -$84.3K ﹤0.01% 1815
2021
Q2 		$2.86M Buy
104,395
+28,938
+38% +$825K ﹤0.01% 1765
2021
Q1 		$2.77M Buy
75,457
+49,975
+196% +$1.77M ﹤0.01% 1748
2020
Q4 		$957K Buy
25,482
+2,942
+13% +$91K ﹤0.01% 2151
2020
Q3 		$492K Buy
+22,540
New +$473K ﹤0.01% 2298

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RhumbLine Advisers's AHCO Position: Q2 2026 in Review

RhumbLine Advisers reduced its AdaptHealth (AHCO) stake by 16% in Q2 2026, selling an estimated $544K and leaving 261,632 shares worth $2.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1785.

RhumbLine Advisers first reported a position in AHCO in Q3 2020 and has held it in 24 quarters since. The position peaked at $4.31M in Q3 2022. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • RhumbLine Advisers held 261,632 shares of AdaptHealth worth $2.73M as of Q2 2026.
  • RhumbLine Advisers sold 48,760 AdaptHealth shares in Q2 2026, an estimated $544K.
  • AdaptHealth made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1785 holding.
  • RhumbLine Advisers first reported a position in AdaptHealth in Q3 2020 and has held it in 24 quarters since.
  • RhumbLine Advisers's AdaptHealth position peaked at $4.31M in Q3 2022.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.